Sana Biotechnology Inc [SANA] stock is trading at $2.78, up 9.02%. An important factor to consider is whether the stock is rising or falling in short-term value. The SANA shares have gain 18.30% over the last week, with a monthly amount drifted -24.04%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on November 05, 2024, when JMP Securities downgraded its rating to a Mkt Perform. Previously, Rodman & Renshaw started tracking the stock with Buy rating on June 26, 2024, and set its price target to $16. On January 16, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $12 on the stock. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $9 on September 25, 2023. Citigroup initiated its recommendation with a Buy and recommended $8 as its price target on September 05, 2023. In a note dated May 02, 2023, H.C. Wainwright initiated an Neutral rating.
Sana Biotechnology Inc [SANA] stock has fluctuated between $2.29 and $12.00 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $2.78 at the most recent close of the market. An investor can expect a potential return of 187.77% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.94 and Total Capital is -0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.61 points at the first support level, and at 2.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.89, and for the 2nd resistance point, it is at 3.00.
Ratios To Look Out For
For context, Sana Biotechnology Inc’s Current Ratio is 4.47. On the other hand, the Quick Ratio is 4.47, and the Cash Ratio is 2.7.
Transactions by insiders
Recent insider trading involved Hardy Nathan, Former CFO, that happened on Nov 26 ’24 when 91607.0 shares were purchased. Former CFO, NATHAN HARDY completed a deal on Nov 25 ’24 to buy 25933.0 shares. Meanwhile, Officer NATHAN HARDY bought 45796.0 shares on Oct 21 ’24.
